PRICES include / exclude VAT
Homepage>ISO Standards>ISO 20186-2:2019-Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood-Part 2: Isolated genomic DNA
Sponsored link
download between 0-24 hoursReleased: 2019
ISO 20186-2:2019-Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood-Part 2: Isolated genomic DNA

ISO 20186-2:2019

ISO 20186-2:2019-Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood-Part 2: Isolated genomic DNA

Format
Availability
Price and currency
English PDF
Immediate download
155.00 EUR
English Hardcopy
In stock
155.00 EUR
French PDF
Immediate download
155.00 EUR
French Hardcopy
In stock
155.00 EUR
Standard´s number:ISO 20186-2:2019
Pages:20
Edition:1
Released:2019
DESCRIPTION

ISO 20186-2:2019


This document gives guidelines on the handling, storage, processing and documentation of venous whole blood specimens intended for genomic DNA examination during the pre-examination phase before a molecular examination is performed. This document covers specimens collected in venous whole blood collection tubes. This document is applicable to any molecular in vitro diagnostic examination performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities. Different dedicated measures are taken for stabilizing blood cell free circulating DNA, which are not described in this document. NOTE Circulating cell free DNA in blood is covered in ISO 20186-3. Different dedicated measures are taken for collecting, stabilizing, transporting and storing capillary blood as well as for collecting and storing blood by paper based technologies or other technologies generating dried blood. These are not described in this document. This document does not cover the isolation of specific blood cells and subsequent isolation of genomic DNA therefrom. DNA in pathogens present in blood is not covered by this document.